Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
estrogen nuclear receptor alpha | 59 | 0 | 0 | 59 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Lck | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 1 | 2 |
Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
TDP1 protein | 44 | 0 | 0 | 44 |
glucocorticoid receptor [Homo sapiens] | 36 | 0 | 0 | 36 |
estrogen-related nuclear receptor alpha | 47 | 0 | 0 | 47 |
thyroid hormone receptor beta isoform 2 | 35 | 0 | 0 | 35 |
lamin isoform A-delta10 | 36 | 0 | 0 | 36 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 25 | 0 | 0 | 25 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 37 | 0 | 0 | 37 |
AR protein | 53 | 0 | 0 | 53 |
nuclear receptor subfamily 1, group I, member 3 | 31 | 0 | 0 | 31 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 28 | 0 | 0 | 28 |
pregnane X nuclear receptor | 36 | 0 | 0 | 36 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 23 | 0 | 0 | 23 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 11 | 0 | 0 | 12 |
heat shock protein beta-1 | 15 | 0 | 0 | 15 |
importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
snurportin-1 | 4 | 0 | 0 | 4 |
tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 4 | 0 | 0 | 4 |
Voltage-dependent calcium channel gamma-2 subunit | 19 | 0 | 0 | 19 |
Bile salt export pump | 0 | 42 | 0 | 42 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-beta | 0 | 2 | 1 | 4 |
Glutamate receptor 2 | 19 | 0 | 0 | 19 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 8 | 0 | 0 | 8 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 2 | 0 | 2 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 17 | 0 | 0 | 17 |
Ataxin-2 | 22 | 0 | 0 | 22 |
Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 11 | 0 | 0 | 11 |
HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
Endoplasmin | 0 | 0 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
5'-nucleotidase | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 4 | 1 | 5 |
Delta-type opioid receptor | 0 | 5 | 1 | 6 |
Kappa-type opioid receptor | 0 | 3 | 2 | 5 |
Endoplasmin | 0 | 1 | 1 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 7 | 0 | 0 | 7 |
Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 1 | 2 |
Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 13 | 0 | 0 | 13 |
Luciferase | 20 | 0 | 0 | 20 |
glp-1 receptor, partial | 14 | 0 | 0 | 14 |
hypoxia-inducible factor 1 alpha subunit | 15 | 0 | 0 | 15 |
ATAD5 protein, partial | 18 | 0 | 0 | 18 |
Fumarate hydratase | 13 | 0 | 0 | 13 |
GLI family zinc finger 3 | 33 | 0 | 0 | 33 |
caspase 7, apoptosis-related cysteine protease | 8 | 0 | 0 | 8 |
progesterone receptor | 28 | 0 | 0 | 28 |
retinoic acid nuclear receptor alpha variant 1 | 38 | 0 | 0 | 38 |
retinoid X nuclear receptor alpha | 33 | 0 | 0 | 33 |
farnesoid X nuclear receptor | 26 | 0 | 0 | 26 |
polyprotein | 13 | 0 | 0 | 13 |
67.9K protein | 11 | 0 | 0 | 11 |
peroxisome proliferator activated receptor gamma | 27 | 0 | 0 | 27 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 30 | 0 | 0 | 30 |
caspase-3 | 8 | 0 | 0 | 8 |
IDH1 | 13 | 0 | 0 | 13 |
euchromatic histone-lysine N-methyltransferase 2 | 38 | 0 | 0 | 38 |
aryl hydrocarbon receptor | 20 | 0 | 0 | 20 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 25 | 0 | 0 | 25 |
nuclear receptor subfamily 1, group I, member 2 | 8 | 0 | 0 | 8 |
Histone H2A.x | 18 | 0 | 0 | 18 |
cellular tumor antigen p53 isoform a | 11 | 0 | 0 | 11 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 9 | 0 | 0 | 9 |
chromobox protein homolog 1 | 21 | 0 | 0 | 21 |
transcriptional regulator ERG isoform 3 | 4 | 0 | 0 | 4 |
histone deacetylase 9 isoform 3 | 9 | 0 | 0 | 9 |
mitogen-activated protein kinase 1 | 13 | 0 | 0 | 13 |
urokinase-type plasminogen activator precursor | 6 | 0 | 0 | 6 |
plasminogen precursor | 6 | 0 | 0 | 6 |
urokinase plasminogen activator surface receptor precursor | 6 | 0 | 0 | 6 |
geminin | 33 | 0 | 0 | 33 |
Vif | 0 | 0 | 0 | 1 |
peripheral myelin protein 22 | 21 | 0 | 0 | 21 |
survival motor neuron protein isoform d | 17 | 0 | 0 | 17 |
muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 9 | 0 | 0 | 9 |
ATP-binding cassette sub-family C member 3 | 0 | 28 | 0 | 28 |
Multidrug resistance-associated protein 4 | 0 | 28 | 0 | 28 |
Interferon beta | 28 | 0 | 0 | 28 |
Cellular tumor antigen p53 | 32 | 0 | 0 | 32 |
Integrin beta-3 | 7 | 1 | 0 | 8 |
Integrin alpha-IIb | 7 | 1 | 0 | 8 |
Methionine aminopeptidase | 0 | 3 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 26 | 0 | 26 |
endonuclease IV | 5 | 0 | 0 | 5 |
thioredoxin reductase | 26 | 0 | 0 | 26 |
nonstructural protein 1 | 8 | 0 | 0 | 8 |
G | 19 | 0 | 0 | 19 |
alpha-galactosidase | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 37 | 0 | 0 | 37 |
cytochrome P450 3A4 isoform 1 | 24 | 0 | 0 | 24 |
muscarinic acetylcholine receptor M1 | 15 | 0 | 0 | 15 |
Gamma-aminobutyric acid receptor subunit pi | 24 | 4 | 2 | 30 |
HLA class I histocompatibility antigen, B alpha chain | 19 | 0 | 0 | 19 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 4 | 7 |
Gamma-aminobutyric acid receptor subunit beta-1 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit delta | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 3 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 24 | 4 | 2 | 30 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 24 | 4 | 2 | 30 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Alpha-synuclein | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 3 | 6 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 24 | 5 | 2 | 31 |
Gamma-aminobutyric acid receptor subunit beta-3 | 24 | 4 | 2 | 30 |
Gamma-aminobutyric acid receptor subunit beta-2 | 24 | 4 | 2 | 30 |
GABA theta subunit | 24 | 4 | 2 | 30 |
Inositol hexakisphosphate kinase 1 | 19 | 0 | 0 | 19 |
Gamma-aminobutyric acid receptor subunit epsilon | 24 | 4 | 2 | 30 |
cytochrome P450 2C9, partial | 19 | 0 | 0 | 19 |
glucocerebrosidase | 7 | 0 | 0 | 7 |
DNA polymerase kappa isoform 1 | 15 | 0 | 0 | 15 |
histone acetyltransferase KAT2A isoform 1 | 13 | 0 | 0 | 13 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 2 | 2 | 4 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Microtubule-associated protein tau | 19 | 0 | 0 | 19 |
arylsulfatase A | 10 | 0 | 0 | 10 |
Bloom syndrome protein isoform 1 | 16 | 0 | 0 | 16 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 2 | 2 |
Chain A, SERUM ALBUMIN | 0 | 0 | 2 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 17 | 0 | 0 | 17 |
Chain A, HADH2 protein | 13 | 0 | 0 | 13 |
Chain B, HADH2 protein | 13 | 0 | 0 | 13 |
Chain A, 2-oxoglutarate Oxygenase | 14 | 0 | 0 | 14 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 6 | 0 | 0 | 6 |
Chain A, Cruzipain | 8 | 0 | 0 | 8 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
phosphopantetheinyl transferase | 14 | 0 | 0 | 14 |
USP1 protein, partial | 18 | 0 | 0 | 18 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
aldehyde dehydrogenase 1 family, member A1 | 29 | 0 | 0 | 29 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 5 | 0 | 0 | 5 |
vitamin D3 receptor isoform VDRA | 19 | 0 | 0 | 19 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 5 | 0 | 0 | 5 |
nuclear receptor ROR-gamma isoform 1 | 14 | 0 | 0 | 14 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 3 | 0 | 0 | 3 |
caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 8 | 0 | 0 | 8 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 7 |
Trypsin | 0 | 2 | 0 | 3 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Aromatase | 0 | 4 | 0 | 4 |
Tissue factor | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, adipocyte | 0 | 3 | 1 | 4 |
Prostaglandin G/H synthase 2 | 0 | 9 | 2 | 12 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 3 | 3 |
Histamine H2 receptor | 13 | 2 | 3 | 20 |
10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Calmodulin | 0 | 1 | 1 | 3 |
Disintegrin and metalloproteinase domain-containing protein 17 | 4 | 0 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Solute carrier organic anion transporter family member 2A1 | 0 | 3 | 0 | 6 |
Fatty acid-binding protein 5 | 0 | 2 | 0 | 2 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
Lanosterol 14-alpha demethylase | 0 | 3 | 1 | 4 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
10 kDa chaperonin | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 7 | 0 | 8 |
Cytosolic phospholipase A2 gamma | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 7 | 0 | 8 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
NFKB1 protein, partial | 6 | 0 | 0 | 6 |
GLS protein | 16 | 0 | 0 | 16 |
thyroid stimulating hormone receptor | 18 | 0 | 0 | 18 |
cytochrome P450 2C19 precursor | 8 | 0 | 0 | 8 |
flap endonuclease 1 | 9 | 0 | 0 | 9 |
DNA polymerase iota isoform a (long) | 14 | 0 | 0 | 14 |
lethal factor (plasmid) | 11 | 0 | 0 | 11 |
Cytochrome P450 3A4 | 0 | 7 | 0 | 9 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 3 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 2 | 0 | 3 |
Nitric oxide synthase, inducible | 0 | 1 | 1 | 4 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 13 | 0 | 0 | 13 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 9 | 0 | 0 | 9 |
hypothetical protein, conserved | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 23 | 0 | 0 | 23 |
cytochrome P450 2D6 | 21 | 0 | 0 | 21 |
peroxisome proliferator-activated receptor delta | 20 | 0 | 0 | 20 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 6 | 0 | 6 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Epidermal growth factor receptor | 0 | 4 | 0 | 4 |
Carbonic anhydrase 1 | 0 | 12 | 0 | 15 |
Carbonic anhydrase 2 | 0 | 12 | 0 | 16 |
Fatty acid-binding protein, liver | 0 | 4 | 0 | 4 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 2 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 7 | 0 | 7 |
Adenosine receptor A1 | 0 | 3 | 0 | 4 |
Adenosine receptor A2a | 0 | 3 | 0 | 4 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 9 | 1 | 1 | 11 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 1 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 10 | 0 | 13 |
5-hydroxytryptamine receptor 4 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M2 | 0 | 14 | 3 | 21 |
Muscarinic acetylcholine receptor M4 | 0 | 11 | 3 | 17 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 2 | 11 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 2 | 10 |
Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 11 | 3 | 17 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 1 | 10 |
Muscarinic acetylcholine receptor M1 | 0 | 11 | 3 | 18 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 11 | 3 | 17 |
Alpha-1D adrenergic receptor | 0 | 9 | 2 | 13 |
5-hydroxytryptamine receptor 2C | 0 | 9 | 0 | 9 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 2 |
Muscarinic acetylcholine receptor | 0 | 3 | 1 | 4 |
pregnane X receptor | 8 | 0 | 0 | 8 |
SMAD family member 2 | 16 | 0 | 0 | 16 |
SMAD family member 3 | 16 | 0 | 0 | 16 |
estrogen receptor 2 (ER beta) | 21 | 0 | 0 | 21 |
activating transcription factor 6 | 12 | 0 | 0 | 12 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 14 | 0 | 0 | 14 |
thyroid hormone receptor beta isoform a | 13 | 0 | 0 | 13 |
potassium voltage-gated channel subfamily H member 2 isoform d | 13 | 0 | 0 | 13 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 11 | 0 | 0 | 11 |
acetylcholinesterase | 15 | 0 | 0 | 15 |
P53 | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 19 | 0 | 0 | 19 |
peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 7 | 0 | 0 | 7 |
Bile salt export pump | 0 | 9 | 0 | 9 |
Protein-arginine deiminase type-4 | 0 | 7 | 0 | 7 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 8 | 0 | 8 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 8 | 0 | 0 | 8 |
Caspase-7 | 2 | 0 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 2 | 1 | 3 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 7 | 0 | 0 | 7 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
ClpP | 1 | 0 | 0 | 1 |
electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
TSHR protein | 2 | 0 | 0 | 2 |
Smad3 | 6 | 0 | 0 | 6 |
apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
Parkin | 4 | 0 | 0 | 4 |
LacZ protein (plasmid) | 0 | 0 | 1 | 1 |
XBP1 | 0 | 1 | 0 | 1 |
serine-protein kinase ATM isoform a | 6 | 0 | 0 | 6 |
lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 6 | 0 | 0 | 6 |
type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 8 | 0 | 0 | 8 |
glucokinase regulatory protein | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 5 | 0 | 0 | 5 |
ras-related protein Rab-9A | 9 | 0 | 0 | 9 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
serine/threonine-protein kinase PLK1 | 4 | 0 | 0 | 4 |
apelin receptor | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 2 | 0 | 4 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
Vpr | 3 | 0 | 0 | 3 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
Rap guanine nucleotide exchange factor 3 | 5 | 0 | 0 | 5 |
Amyloid-beta precursor protein | 1 | 3 | 0 | 4 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
Guanine nucleotide-binding protein G | 6 | 0 | 0 | 6 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 2 |
GALC protein | 5 | 0 | 0 | 5 |
thyrotropin-releasing hormone receptor | 7 | 0 | 0 | 7 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 3 | 0 | 5 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 3 | 0 | 5 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 7 | 0 | 10 |
Carbonic anhydrase | 0 | 3 | 0 | 4 |
Carbonic anhydrase 15 | 0 | 5 | 0 | 6 |
Caspase-2 | 0 | 0 | 1 | 1 |
PPM1D protein | 8 | 0 | 0 | 8 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
Spike glycoprotein | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 2 | 2 | 4 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
DNA ligase | 0 | 1 | 0 | 1 |
Riboflavin-binding protein | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 0 | 2 | 2 |
Histidine-rich protein PFHRP-II | 0 | 2 | 0 | 3 |
Procathepsin L | 0 | 3 | 2 | 5 |
Alpha-2A adrenergic receptor | 0 | 16 | 2 | 19 |
Replicase polyprotein 1a | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Spike glycoprotein | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 3 | 2 | 5 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 11 | 0 | 12 |
Alpha-2C adrenergic receptor | 0 | 11 | 2 | 14 |
DNA ligase 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 21 | 2 | 2 | 25 |
Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
DNA ligase A | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 14 | 0 | 14 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 2 | 2 | 4 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
ORF73 | 0 | 0 | 1 | 1 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
Thrombopoietin | 4 | 0 | 0 | 4 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 10 | 0 | 0 | 10 |
caspase-3 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
Albumin | 0 | 4 | 6 | 11 |
Albumin | 0 | 0 | 2 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 1 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 11 | 0 | 18 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 2 | 1 | 3 |
Cytochrome P450 2D6 | 0 | 7 | 1 | 8 |
Cytochrome P450 2C9 | 0 | 12 | 0 | 12 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 5 | 0 | 5 |
D(2) dopamine receptor | 0 | 4 | 0 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 5 | 0 | 5 |
Alpha-1B adrenergic receptor | 0 | 13 | 2 | 15 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 6 | 2 | 8 |
Alpha-2B adrenergic receptor | 0 | 8 | 1 | 9 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 6 | 0 | 6 |
D(1A) dopamine receptor | 0 | 3 | 0 | 4 |
D(4) dopamine receptor | 0 | 5 | 0 | 6 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 8 | 1 | 9 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 8 | 1 | 9 |
Alpha-1D adrenergic receptor | 0 | 13 | 2 | 15 |
Sodium-dependent noradrenaline transporter | 0 | 6 | 1 | 7 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Histamine H2 receptor | 0 | 7 | 2 | 9 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
Histamine H1 receptor | 0 | 2 | 4 | 7 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 11 | 2 | 13 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 2 | 6 |
D(3) dopamine receptor | 0 | 7 | 0 | 8 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 13 | 2 | 15 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2J2 | 0 | 10 | 0 | 10 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
D(2) dopamine receptor | 0 | 5 | 1 | 7 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 2 | 6 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 2 | 6 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 2 | 6 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
Sodium channel protein type 5 subunit alpha | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 2 | 6 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 6 | 0 | 6 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 2 | 6 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 2 | 6 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 2 | 4 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 4 | 0 | 7 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 4 |
Solute carrier family 22 member 1 | 0 | 6 | 0 | 8 |
Multidrug and toxin extrusion protein 2 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 8 | 0 | 4 | 0 | 7 |
Multidrug and toxin extrusion protein 1 | 0 | 9 | 0 | 9 |
Histamine H4 receptor | 0 | 3 | 2 | 5 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 6 | 0 | 7 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
dopamine D1 receptor | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 4 | 1 | 10 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 2 |
cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
Alpha-1A adrenergic receptor | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Translocator protein | 0 | 2 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
PAX8 | 0 | 0 | 0 | 1 |
STAT3, partial | 0 | 1 | 0 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostacyclin receptor | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 5 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 2 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
RGS12 | 1 | 0 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 2 | 0 | 2 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 10 | 0 | 0 | 10 |
isocitrate dehydrogenase 1, partial | 2 | 0 | 0 | 2 |
LANA | 0 | 0 | 0 | 1 |
NPYLR7B | 0 | 0 | 2 | 2 |
bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 4 | 0 | 0 | 4 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 5 | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 3 | 0 | 3 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Exopolyphosphatase PRUNE1 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
Single-stranded DNA cytosine deaminase | 2 | 0 | 0 | 2 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 3 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
Ultraspiracle | 0 | 4 | 0 | 4 |
20-hydroxy-ecdysone receptor | 0 | 4 | 0 | 4 |
Ecdysone receptor | 0 | 2 | 0 | 2 |
Ecdysone receptor | 0 | 1 | 0 | 1 |
Protein ultraspiracle | 0 | 1 | 0 | 1 |
Ultraspiracle | 0 | 1 | 0 | 1 |
20-hydroxy-ecdysone receptor | 0 | 1 | 0 | 1 |
Ultraspiracle protein | 0 | 1 | 0 | 1 |
20-hydroxy-ecdysone receptor | 0 | 1 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
heat shock protein 90 | 0 | 0 | 1 | 1 |
Glycoprotein hormones alpha chain | 2 | 0 | 0 | 2 |
Genome polyprotein | 0 | 1 | 1 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 3 | 0 | 0 | 3 |
relaxin receptor 1 isoform 1 | 2 | 0 | 0 | 2 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Luciferin 4-monooxygenase | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 3 | 0 | 5 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 0 | 0 | 1 |
Tyrosine-protein phosphatase 1 | 0 | 1 | 0 | 1 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
Vesicular glutamate transporter 3 | 0 | 1 | 0 | 1 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 3 | 0 | 6 |
Carbonic anhydrase 3 | 0 | 3 | 0 | 5 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 5 | 0 | 8 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 7 |
Carbonic anhydrase 7 | 0 | 3 | 0 | 6 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 4 | 0 | 7 |
Carbonic anhydrase 13 | 0 | 3 | 0 | 6 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 3 | 0 | 6 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 6 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Ricin | 0 | 1 | 0 | 1 |
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 0 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 4 | 1 | 5 |
Metabotropic glutamate receptor 5 | 0 | 2 | 1 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
pyruvate kinase | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 2 | 0 | 2 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 1 | 3 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 4 | 0 | 4 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 3 | 0 | 3 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 0 | 2 | 3 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 4 | 4 | 9 |
Beta-1 adrenergic receptor | 0 | 4 | 3 | 7 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-3 adrenergic receptor | 0 | 1 | 3 | 4 |
Beta-1 adrenergic receptor | 0 | 4 | 2 | 7 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1A adrenergic receptor | 0 | 4 | 3 | 11 |
Alpha-1B adrenergic receptor | 0 | 3 | 3 | 8 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 2 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 3 | 3 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 13 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 2 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
Type-1 angiotensin II receptor | 0 | 2 | 0 | 2 |
Malate dehydrogenase, cytoplasmic | 0 | 2 | 0 | 2 |
Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
Leukotriene B4 receptor 1 | 0 | 2 | 0 | 2 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 2 | 0 | 2 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Myc proto-oncogene protein | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 3 | 0 | 1 | 4 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Adenosine transporter 1 | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
Fatty acid synthase | 0 | 1 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Albumin | 0 | 0 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Cruzipain | 0 | 1 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Stromelysin-1 | 0 | 2 | 1 | 3 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 2 | 0 | 2 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 3 | 0 | 3 |
Cholinesterase | 0 | 2 | 0 | 2 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 2 | 0 | 2 |
STE24 | 0 | 0 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Chain A, Adipocyte Lipid-binding Protein | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
putative potassium channel subunit | 0 | 0 | 1 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 0 | 1 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 0 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 0 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 2 | 0 | 2 |
L-lactate dehydrogenase C chain | 0 | 1 | 0 | 1 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase B chain | 0 | 2 | 0 | 2 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 3 |
Endolysin | 0 | 0 | 1 | 1 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 2 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-casein | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-mannosidase 2C1 | 0 | 0 | 1 | 1 |
Bromodomain-containing protein 2 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
galactokinase | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Aurora kinase A | 0 | 1 | 0 | 1 |
Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
BRCA1 | 1 | 0 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
Methionine aminopeptidase 1 | 0 | 1 | 1 | 2 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 0 | 1 | 1 |
Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
Chain A, Dihydrofolate Reductase | 0 | 0 | 1 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, dihydrofolate reductase (DHFR) | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 from Tn4003 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |